{{Rsnum
|rsid=9383938
|Chromosome=6
|position=151666222
|Orientation=plus
|GMAF=0.1667
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 85.8 | 14.2 | 0.0
| HCB | 34.3 | 54.7 | 10.9
| JPT | 45.1 | 43.4 | 11.5
| YRI | 68.5 | 29.5 | 2.1
| ASW | 64.9 | 29.8 | 5.3
| CHB | 34.3 | 54.7 | 10.9
| CHD | 40.4 | 49.5 | 10.1
| GIH | 93.1 | 5.9 | 1.0
| LWK | 84.5 | 15.5 | 0.0
| MEX | 84.5 | 13.8 | 1.7
| MKK | 91.0 | 9.0 | 0.0
| TSI | 75.5 | 24.5 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21263130
|Title=Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study
}}

{{PMID Auto GWAS
  |PMID=22976474
  |Trait=Breast cancer
  |Title=A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
  |RiskAllele=T
  |Pval=2E-10
  |OR=1.28
  |ORtxt=[NR]
  |OA=1
}}

{{PMID Auto
|PMID=25002657
|Title=Breast cancer susceptibility variants and mammographic density phenotypes in Norwegian postmenopausal women
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}